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Abstract
Background. The Bombay phenotype is a rare genetic trait which is characterized by 
the absence of A, B and H antigens on red cells as well as in body secretions. The serum 
shows the presence of antibodies against antigen H. Patients with this rare blood type 
are not easily transfusable. We had observed a woman aged 18, at the 20th week of preg-
nancy, native of Sri Lanka, with an IgG and IgM class anti-H. We report the case and 
the clinical issues arisen.
Materials and methods. The determination of ABO, Rh[D] group, the indirect anti-
globulin test (IAT) were performed in tube techniques and in neutral gel microcolumn.
Detection for antibodies was performed using ID-Card LISS-Coombs microtubes, in 
solid phase and with tube techniques. For molecular analysis, the FUT1 and FUT2 genes 
were sequenced using BigDye terminator v1.1. The study of FUT2 gene was performed 
after extraction of mRNA using Qiagen kit RNase and then reverse-transcribed into 
cDNA.
Results. The Bombay phenotype was confirmed by serological and molecular analysis 
techniques. The patient, in collaboration with a cultural mediator, was informed of her 
immunohaematological condition and a program of assistance was proposed to her. Un-
fortunately the patient did not return for the next visit, despite of a telephone reminder. 
During childbirth a haemorrhage occurred and a request of compatible blood for an 
urgent transfusion arrived at our transfusion service. Fortunately, the haemorrhage was 
arrested and the patient didn’t need to have any transfusions.
Conclusion. This case emphasizes the need for an efficient management of rare blood 
types that are more and more frequent as a result of migration. It is necessary to orga-
nize, in strategic points of the national territory, reference centres with better diagnostic 
capabilities and implement freezing of red blood cells with rare phenotype for diagnostic 
and therapeutical use. Communication issues are as well important in dealing with this 
emerging phenomenon.
INTRODUCTION
The name Bombay, in the world of blood transfusion, 
immediately evokes a rare phenotype of red blood cells 
that recalls the difficulty in finding compatible blood 
[1]. This phenotype finds its maximum concentration in 
the Indian city of Mumbai, previously called “Bombay” 
[2]. We observed a pregnant patient, carrier of this phe-
notype, and in this paper we describe the case and the 
lessons that have emerged from it.
The antigenic molecules A and B are generated by 
the addition of a specific sugar (N-acetylgalactosamine 
and galactose respectively) at the end of the chains of 
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O-glycan and N-glycan that branch off from the mem-
brane proteins and lipids of red blood cells and many 
other cells [1]. In order to perform this addition the two 
specific glycosyl-transferases, need to interact with a 
molecule of fucose in the position α(1-2) of the pre-
terminal galactose of the chain. This also applies to the 
glycoproteins and glycolipids which are secreted from 
exocrine glands and from endothelial cells in plasma. 
The fucosiltransferases responsible for this glycosyl-
ation are the products of two genetic loci: FUT1 and 
FUT2 [3, 4]. 
FUT1 is active in the erythroid and other lines and 
generates a specific fucosiltransferase for Type2 chains 
present in these cells. FUT2, instead, is active in the 
exocrine and endothelial cells of the vessels, acting 
on the fucosylation of Type1 chains in the glycolipids 
and glycoproteins produced by these cells for organic 
secretions and plasma. The wild gene, suitable for the 
synthesis of effective transferases at the FUT1 locus is 
indicated by H, the set of ineffective genes is defined as 
h. At the same time, in the FUT2 locus, genes are indi-
cated respectively, with Se if they are effective and with 
se if ineffective. The presence of only one effective gene 
is sufficient to produce fucosiltransferase [3, 4]. The h 
gene is extremely infrequent in the global population, 
the rare homozygotes h/h have a frequency of 0.0004% 
(1/250 000). As previoulsy mentioned, there is a niche 
of greater expression on the western coast of the Indian 
subcontinent, where the city of Mumbai has the highest 
frequency, about 1/10,000 inhabitants. Individuals with 
the pair of allele Se/Se and Se/se are defined secretor, 
while non-secretor subjects are defined by the pair of 
allele se/se where they have a global frequency of around 
22% [4, 5].
At the base of the Bombay phenotype, whose symbol 
is Oh, there is a double homozygous condition h/h and 
se/se, so individuals with this genotype will not produce 
the H molecule and therefore their red blood cells do 
not exhibit A and B molecules [4, 5]. The absence of 
substance H in Oh, leads to immunization against this 
substance present in the sugary wall of the bacteria that 
colonize the large human intestine: these antibodies, 
generally IgM, have a wide spectrum of thermal activ-
ity, and they are capable of triggering a serious intravas-
cular haemolytic transfusion reaction [6, 7]. An anti-H 
antibody reacts with all cells except Oh. Individuals with 
genotype homozygous h/h, coupled with the presence 
of a gene Se, result in a strong reduction of H, A and B 
antigens on the surface of red blood cells, but not their 
absence, given only by plasma absorption. No anti-H 
antibodies are formed. This phenotype is called para-
Bombay [4].
SUBJECT, METHODS AND RESULTS
Subject
P.R.P.M., a pregnant woman at the 20th week of 
pregnancy, aged 18, originally from Sri Lanka, under-
went the determination of the ABO, Rh[D] group and 
the indirect antiglobulin test (IAT) at our transfusion 
service. There was a discrepancy in cell and serum ABO 
grouping test, and reaction with all three cells test in 
IAT: this led to the suspicion of a rare blood type.
Methods in serological analysis
The ABO phenotyping was carried out by the stan-
dard forward grouping test by using commercial anti-
sera anti-A, anti-B, anti-AB, anti-H (Antisera Immuno-
diagnostic GmbH). Reverse grouping was performed 
using A1, A2, B and O cells 3% in Saline 0.9% in tube 
techniques and in neutral DiaMed microcolumn.
The research for antibodies was performed using ID-
Card LISS-Coombs microtubes containing anti-IgG 
and anti-C3d within the gel matrix and neutral, at 37 
°C (DiaMed with 3 + 11 cells test untreated and 11 also 
treated with papain), in solid phase at 37 °C (Capture 
Ready ID, Extended I and II, Immucor) and with tube 
techniques at 20 °C (two Panel Twenty Immucor). Elu-
tion with acid glycine was performed using Red Cells 
Elute by Lorne Laboratories LTD. 
Methods in molecular analysis
For molecular analysis, the FUT1 and FUT2 genes 
were sequenced using BigDye terminator v1.1 (Thermo 
Fisher Scientific), using the primers described in the lit-
erature [8, 9].
The study of FUT2 gene was performed after ex-
traction of mRNA using Qiagen kit RNase and then 
reverse-transcribed into cDNA. The same procedure 
and the PCR technique were performed on two control 
samples using the same primers.
RESULTS
The typing of the patient’s red blood cells with anti-A, 
anti-B and anti-AB showed no reactivity, addressing the 
diagnosis towards group O. Reverse grouping was per-
formed to identify ABO agglutinins, with known pooled 
A1, A2, B and O cells: the sample showed agglutina-
tion with homogeneous score 4+ with each of them. 
The IAT was positive showing agglutination with score 
4+ each of the 3 cells test. The differential diagnosis 
was between a Bombay phenotype and an autoimmune 
disease supported by an IgM antibody. DAT (Direct 
Antiglobulin Test), the self-control that was executed at 
37 °C and 20 °C and typing of the red blood cells using 
the anti-H lectin of dolicus biflora, were negative (as 
shown in Figure 1). At this point the suspected diagno-
sis of Bombay phenotype was forcefully supported: the 
Figure 1 
ABO reverse grouping test: the sample shows agglutination 
with homogeneous score 4+ with each of them. The self-con-
trol and typing of the red blood cells using the anti-H lectin of 
dolicus biflora, are negative.
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antigenic structure of the red blood cells, the specific-
ity of the antibody present in the serum, and the gene 
structure of the H and Se locus were thoroughly studied 
[10, 11]. Informed consent for molecular analysis was 
obtained from the patient before collecting her blood 
sample. Genomic DNA was prepared from peripheral 
blood leukocytes by standard procedures. The PCR 
product of both FUT genes was directly sequenced. 
The sequencing of the entire coding region of FUT1 
showed a mutation T725G (as shown in Figure 2) and 
the sequencing for that of FUT2, a 10 Kb deletion, both 
in homozygous condition. This genotype has been de-
scribed as a characteristic of individuals with non-secre-
tor Bombay phenotype [4, 12]. 
The patient, in collaboration with a cultural mediator, 
was informed in detail of the two risks associated with 
his immunohaematological condition: 
• the risk of foetal and neonatal haemolytic disease 
(EDFN) given the presence of an important IgG 
component of anti-H;
• the risk of absence of compatible donor blood for 
transfusion in the event of post-partum haemorrhage 
or any pathological event requiring transfusion ther-
apy [13-16].
Unfortunately the patient did not return for the next 
check, even after a telephone reminder. The patient was 
hospitalized at the end of the expected period of preg-
nancy, without advising either our transfusion service 
or the centre for pregnancies at risk. During childbirth 
a haemorrhage occurred and a request of compatible 
blood for an urgent transfusion arrived at our transfu-
sion service. Fortunately, the haemorrhage was arrested 
and the patient didn’t need to have a hysterectomy. The 
new-born was born healthy and with O, Rh[D] group. 
The patient showed during her pregnancy poor compli-
ance that led to the inability to carry out pre-deposit 
and implementation of planned interventions to prevent 
and counteract possible adverse events related to the 
case. Events that, in fact, occurred during childbirth. It 
is possible that this is linked to the cultural background 
of the patient with behaviour and traditions related to 
childbirth, which do not provide medical support and 
hospitalization.
DISCUSSION
In this study, a case of non-secretor Bombay pheno-
type, diagnosed in our transfusion service, was report-
ed. This genotype is relatively common in the south-
east area of the Indian sub-continent, but in Italy it is 
almost inexistent and is defined as from a “rare group”. 
Ongoing migratory processes, cause an increased fre-
quency in Italy of people with red blood cell pheno-
types present mainly or exclusively in non-caucasic 
populations. These processes have become more fre-
quent and significant and they are having an impor-
tant impact on the ethnic composition and genetic-
antigenic characteristics of the Italian population even 
more rapidly than we may have thought, taking into 
account only the “number” of immigrants present [16]. 
The increasing immigration present in Italy implies 
the progressive development of a multiethnic society, 
in which a very high number of patients from differ-
ent ethnic groups, are from rare blood groups. Most 
foreigners come from Central and Eastern Europe, 
North and Central Africa, some Asian countries and 
Central and South America.
In this period, in fact, the low rate of fertility of the 
indigenous Italian population, is counteracted by the 
relatively high birth rate among immigrants, especially 
those from Africa, Asia and Latin America [17]. In our 
region, in the last three years, with an immigrant popu-
lation of around 10%, the percentage of infants with 
foreign parents is 30%, of these, about 10% have only 
one foreign parent as shown in Table 1 and Table 2. We 
have passed from one multi-ethnic reality, but essen-
tially stable for centuries, to a new multiethnicity. This 
presents a new challenge for our transfusion system, we 
can accept and address this challenge by borrowing sug-
gestions from countries that have experienced this situ-
ation before us [18].
Table 1
Children born to the Careggi’s Hospital (Florence, Italy) by parents with different nationalities
Births at Careggi’ s Hospital, years 2014, 2015 and 2016
Years Both Italian 
parents
Both foreign 
parents
Mother foreign 
Father Italian
Mother Italian 
Father foreign
No response Total
N % N % N % N %
2014 2577 71.0 681 18.4 218 5.9 152 4.1 72 3700
2015 2526 70.5 718 19.8 262 7.2 79 2.2 38 3623
2016 2430 69.6 675 19.2 274 7.8 113 3.2 32 3524
Total 7533 70.4 2074 19.1 754 7.0 344 3.2 142 10 847
Figure 2 
Sanger sequencing for evaluation of SNP presence in FUT1 
exon 4, primer pair 3. The arrow shows the SNP (Single Nucleo-
tide polymorphism) sequence related to L242R (c. 725 T>G). 
The panel to left shows the SNP homozygote in sample by 
direct sequencing. The Panel to right shows the wildtype se-
quencing of a control DNA.
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In many western countries the main transfusion or-
ganizations have promoted the creation of rare group 
donor registers or banks, coordinated by a central im-
munohaematology laboratory. This has been estab-
lished in the European Union with the National Frozen 
Blood Bank (UK), the Frozen Blood Council (EU) and 
the BNSPR Banque Nationale de Sang de Paris and 
in the United States with the New York Blood Center, 
the ARDP American Rare Donor Program Philadelphia 
and in the eastern countries The Shanghai Blood Cen-
ter and the Japanese Red Cross.
In Italy, only the Lombardy region in 2004 estab-
lished the Bank of rare blood group components – Cen-
tro di Riferimento della Regione Lombardia (Lombardy 
Region Reference Center) at the Centro Trasfusionale 
Fondazione IRCC Ca’ Granda (Transfusion Center of 
the IRCC Ca’ Granda Foundation) (Ospedale Maggio-
re Policlinico) of Milan, which has a register of donors 
and a supply of (frozen) blood from rare groups.
This bank is essential for managing requests for blood 
in cases of complex immunization. By “rare blood” it is 
understood a type of blood that has a combination of 
uncommon antigens. A donor is defined as from a “rare 
group” when his/her antigenic structure is found in at 
most 1 subject for every 1000-5000 examined. The neg-
ative subjects for high incidence antigens, defined as 
carriers of “extremely rare” groups, are found, however, 
with an even lower frequency (<1:5000). These blood 
groups do not pose health problems but underscore 
evident difficulties in the management of transfusions. 
In such cases it is obviously very difficult to find blood 
units suitable for transfusion: the availability of a “Rare 
Group Donor Register” permits the convening the ap-
propriate donors at the time of need for transfusion of 
the patients described above, in this way the establish-
ment of a rare unit frozen blood unit bank allows for the 
creation of stocks necessary to respond to the transfu-
sion emergencies that may arise.
In Italy, blood donors are still almost all of Italian 
origin and as a result, there is great difficulty in finding 
blood bags from rare groups. In Tuscany, even if there 
is no Rare Blood Bank, such as the one in Lombardy, 
the Avis Regione Toscana in collaboration with the Uni-
versity of Pisa, has at least promoted a series of initia-
tives aimed at understanding how the communities of 
foreign immigrants in Tuscany relate to the donation of 
blood, on the basis of the relative peculiar cultural as-
sumptions and models of citizenship. These campaigns 
to raise awareness highlight the need to implement 
targeted strategies to encourage donations from ethnic 
minorities and attempt to overcome cultural barriers as 
well as promote an increase in social solidarity.
In order to facilitate and thus obtain effective results 
from raising awareness for donations by foreigners, it 
would be fundamental to import to the various Ital-
ian regions the Lombardy model as mentioned above, 
where a “Rare Groups Blood Bank” was created as well 
as a “Donor Register”. The National Blood Center 
could be designated for coordination among the various 
regional structures, to make it possible to retrieve the 
blood of rare groups even beyond the territorial bound-
aries of the Regions.
This would represent a significant step forward in 
the solution of transfusion problems related to the rar-
ity of blood groups in the area and would also allow a 
better and more effective management of human and 
non-human resources engaged in the sector, as well as a 
rationalization of costs [19-21] .
CONCLUSION
The case described has given us many relevant points 
of discussion. It highlights how the National Health 
System does not take charge of solving the problems 
that result from the presence in a modern society of 
a growing number of people with different origins and 
cultural characteristics thereby causing the dysfunc-
tions mentioned in the present study which are inher-
ent to structural shortcomings as well as communica-
tion problems, that are destined to occur over and over 
again. In fact, the State should be the first and most 
important source of communication with all its citizens, 
as well as patients in healthcare facilities, including and 
above all through pre-established structures, organized 
and equipped with the necessary expertise. A central-
ized structure, holding donor registers and blood stocks 
of rare groups, with decentralized and coordinated 
branches, would facilitate health and hospital units 
present on the territory with the management of the 
most complex cases from the point of view of transfu-
sions. This should be accompanied by an appropriate 
implementation of information campaigns aimed at en-
couraging the donation of blood components by people 
from all the different ethnic groups, who live together 
in the same territory.
At the moment, in the sectors in which the protec-
tion of an individual’s health is left to the mere willing-
Table 2
Children born in Tuscany Region (Italy) to parents of different nationalities
Births in Tuscany, years 2014, 2015 and 2016
Years Both Italian parents Both foreign 
parents
Mother foreign
Father Italian
Mother Italian
Father foreign
No response Total
N % N % N % N %
2014 19 746 70.9 5571 20.0 1962 7.0 556 2.0 1180 29 015
2015 18 939 70.9 5330 20.0 1986 7.4 461 1.7 965 27 681
2016 17 994 69.1 5495 21.1 1992 7.6 572 2.2 1314 27 367
Total 56 679 70.3 16 396 20.3 5940 7.4 1 589 2.0 3459 84 063
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ness of health personnel, in the absence of guidelines 
and structures, such as those indicated and hypoth-
esized above, the management difficulties in assisting 
patients with rare blood groups, can even become in-
surmountable. 
A State that does not equip itself with the necessary 
and appropriate tools to create effective communica-
tion with all its citizens, and therefore including those 
who need special health care/treatment, to make them 
aware of their pathophysiological situations, associated 
risks as well as the preventive and therapeutic possibili-
ties available to them, cannot demand from them the 
active participation that is necessary for achieving the 
“health” objective, common to all.
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